2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition

COMPREHENSIVE SESSIONS Offer Practical Education Over 100 sessions and symposia that provide essential practice guidelines and innovative treatment strategies are at your disposal during Congress. You’ll find interactive discussions incorporating case studies, Q&A sessions and more for a variety of today’s hottest topics. No matter what your educational or professional goals are, Congress has a multitude of sessions to fit the bill! For an in-depth look at important practice-related issues, look for the HOT! icon. The program for the 2008 U.S. Psychiatric and Mental Health Congress evolves during the months leading up to the Congress. Educational programs are released as they are finalized and changes will be reflected on our web site at www.CMELLC.com/psychcongress when they become available. Please review the preliminary schedule and familiarize yourself with your desired daily agenda. Seating is limited for all sessions and Industry-Supported Symposia, and is available on a first-come, first-served basis. Please plan to arrive early. All sessions are 1.25 credit hours unless specified otherwise. Thursday, Oct. 30 7:00-9:00 a.m. 11-0 Managing the Complex Patient with Insomnia and Comorbid Conditions: Rationale for Treatment Selection PI PT Breakfast symposia • 1.5 credits This program is supported by an educational grant from Takeda Pharmaceuticals North America, Inc. status epilepticus, coma and subarachnoid hemorrhage; 2) Describe pupillomotor function in CNIII Palsies and prognosis; and 3) Incorporate cost-effective testing and apply principles to treatment and rehabilitation. 13-1 RX HOT! Placebo Response in Psychiatric Illness 9:30-10:45 a.m. 12-0 Adolescent and Adult ADHD 12-1 Globesity: Crisis, Prospects and New Treatments AP PD RX HOT! The rising epidemic of obesity is called “globesity” by wHO and is affecting millions of people worldwide. By participating in this activity, attendees will be able to: 1) List major illnesses associated with obesity; 2) Discuss the epidemiology of obesity and overweight; and 3) Assess current theories, current treatment approaches—including minimally invasive surgery—and experimental approaches that have resulted from tests concluding that highly palatable, erotic and exotic foods act in the brain as a drug of abuse. Results from studies of psychotropic medications often show a placebo response almost equal to active medication. Does this mean medications used to treat mental illness are no more effective than placebo? By participating in this activity, attendees will be able to: 1) Analyze typical medication study designs; 2) Assess the results of recent psychotropic medications studies; and 3) Discuss the place "placebo" has in medical treatment. By participating in this activity, attendees will be able to: 1) Describe the prevalence of comorbid conditions associated with insomnia and the importance of identifying and managing insomnia as a comorbid condition rather than a secondary condition; 2) Investigate the role of risk/benefit analysis in the selection of insomnia pharmacotherapy; and 3) Evaluate current and emerging data relevant to the care of patients with chronic insomnia. 13-2 Safety Concerns in the Treatment of Pediatric Depression CA PD It is estimated that depression affects 5% of adolescents. The risk of increased suicidal ideation and completed suicides when treating children and adolescents with SSRIs—the the mainstay of depression pharmacotherapy—versus leaving the depression untreated have made treating depression in the 8:00-9:15 a.m. 11-1 Virtual War, Real Healing? Veterans and PTSD CAM VT Universities, private firms and the federal government are spending millions of dollars creating and testing computerized virtual reality to help ease the psychiatric disorders in combat personnel. By participating in this activity, attendees will be able to: 1) Discuss modern computer technology and virtual simulations and how they are used to treat certain psychiatric disorders; 2) Identify the influence of virtual exposure therapy and how it is used to treat patients in the areas of speech pathology, attention-deficit disorder, pain distraction, motor rehabilitation, anxiety disorders and posttraumatic stress disorder; and 3) Assess appropriateness of virtual exposure therapy for individual patients. 12-2 Autonomic Disorders NP This course provides an overview of a clinical approach to diagnosis, evaluation and management of autonomic disorders. By participating in this activity, attendees will be able to: 1) Discuss the clinical cases of orthostatic hypotension, orthostatic intolerance, autonomic neuropathies and disorders of sweating; 2) Discuss patient care by highlighting the ways by which the clinician can provide useful consultations and effectively manage patients suffering from autonomic disorders; and 3) Formulate a differential diagnosis and offer a treatment plan for patients with common and less common varieties of autonomic dysfunction. Customize Your Education With 12 Specialized Tracks Our educational tracks will help you create a schedule that best meets your educational goals. You can devote your time to one track or focus on several topics for a well-rounded perspective. Design your own optimal learning experience and return home with the clinical skills you need most in your practice. 12-3 The Detection of Malingering Using Verbal and Physical "Tells" GP NP 11-2 Introduction to Drug Abuse and Dependency: New Insights From Cocaine to Alcohol AP HOT! Research is improving our understanding of drug dependency and abuse in all areas: from diagnosis to treatment to maintenance of abstinance. By participating in this activity, attendees will be able to: 1) Discuss the latest research findings on abuse and dependency of many substances; 2) Identify areas for future research; and 3) Discuss how to apply research to clinical practice. 11-3 Neurologic Emergencies NP Psychiatrists have heretofore mostly relied on forensic literature and psychological tests such as the MMPI to detect malingering. However, a recent explosion in poker and law-enforcement literature on verbal and physical "tells" has expanded the possibilities for the evaluation of deception. Mental health professionals should be familiar with this new approach. By participating in this activity, attendees will be able to: 1) Review the psychiatric approach to the detection of malingering; 2) Explore the emergence of poker and lawenforcement literature in the area of verbal and physical "tells"; 3) Examine how these "tells" might be used by the clinical psychiatrist to improve patient care. Through the use of case studies, this lecture will update knowledge in recognition and management of acute neurologic disorders that may first present to the psychiatrist. By participating in this activity, attendees will be able to: 1) Identify 13-0 Fibromyalgia AP = addiction Psychiatry CA = Child and adolescent Psychiatry CAM = Complementary and alternative Medicine GP = geriatric Psychiatry NP = neuropsychiatry PI = Practice issues, Ethics and Forensic Psychiatry PD = Psychiatric Disorders PM = Psychosomatic Medicine PT = Psychotherapy RX = Psychopharmacology SC = Social and Community Psychiatry VT = Violence and trauma 10 Register Online and Save at www.CMELLC.com/psychcongress http://www.CMELLC.com/psychcongress http://www.CMELLC.com/psychcongress

Table of Contents Feed for the Digital Edition of 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition

Table of Contents Exhibit Hall Opportunities Industry-Supported Symposia Educational Tracks Comprehensive Sessions Congress Hosts Program Advisory Members Faculty Presenters About San Diego Discounted, Tax-Deductible Tuition Risk-Free Registration

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.